+
FMV Buys Malacca Property to Build Integrated Healthcare Hub
Real Estate

FMV Buys Malacca Property to Build Integrated Healthcare Hub

Fischer Medical Ventures, a leading medical device company listed on the Bombay Stock Exchange, is pleased to announce the successful acquisition of a landmark mixed-use property in Malacca, Malaysia. Strategically located next to the renowned Mahkota Hospital, the property comprises hotel, commercial, and retail components, and will serve as the foundation for FMV’s regional healthcare hub.

This acquisition represents a key milestone in FMV’s strategic growth plan to expand its presence across the healthcare value chain. FMV intends to progressively redevelop portions of the property into integrated healthcare facilities, including health screening centers, specialist clinics, and medical suites. The development will also serve as a direct channel to showcase and distribute FMV’s advanced medical device solutions to healthcare providers and patients.

Chairman of FMV, Ravindran Govindan, commented, “This acquisition is a strategic milestone for FMV. The property’s location—adjacent to Mahkota Hospital in a high-traffic, medically vibrant area—offers us a unique opportunity to reimagine healthcare access in the region. By integrating our innovative medical technologies directly into care environments, we are not only expanding our business reach but also contributing meaningfully to better patient outcomes.”

“This investment supports our broader vision to develop healthcare-enabled real estate assets in key regional centres across Southeast Asia. Malacca, with its strong medical tourism ecosystem and connectivity to Singapore, Indonesia and Philippines, is the ideal starting point,” he added.

The development aligns with FMV’s vision to create sustainable healthcare infrastructure that supports both clinical excellence and commercial scalability. It also serves as a platform for FMV to directly engage with healthcare professionals, patients, and institutional partners in a dynamic setting—accelerating product adoption, training, and after-sales support

The company expects the first phase of redevelopment to commence later this year, subject to regulatory approvals and planning. FMV will work closely with local authorities, medical stakeholders, and international partners to ensure the facility complements Malacca’s role as a key medical tourism destination.

Fischer Medical Ventures, a leading medical device company listed on the Bombay Stock Exchange, is pleased to announce the successful acquisition of a landmark mixed-use property in Malacca, Malaysia. Strategically located next to the renowned Mahkota Hospital, the property comprises hotel, commercial, and retail components, and will serve as the foundation for FMV’s regional healthcare hub.This acquisition represents a key milestone in FMV’s strategic growth plan to expand its presence across the healthcare value chain. FMV intends to progressively redevelop portions of the property into integrated healthcare facilities, including health screening centers, specialist clinics, and medical suites. The development will also serve as a direct channel to showcase and distribute FMV’s advanced medical device solutions to healthcare providers and patients.Chairman of FMV, Ravindran Govindan, commented, “This acquisition is a strategic milestone for FMV. The property’s location—adjacent to Mahkota Hospital in a high-traffic, medically vibrant area—offers us a unique opportunity to reimagine healthcare access in the region. By integrating our innovative medical technologies directly into care environments, we are not only expanding our business reach but also contributing meaningfully to better patient outcomes.”“This investment supports our broader vision to develop healthcare-enabled real estate assets in key regional centres across Southeast Asia. Malacca, with its strong medical tourism ecosystem and connectivity to Singapore, Indonesia and Philippines, is the ideal starting point,” he added.The development aligns with FMV’s vision to create sustainable healthcare infrastructure that supports both clinical excellence and commercial scalability. It also serves as a platform for FMV to directly engage with healthcare professionals, patients, and institutional partners in a dynamic setting—accelerating product adoption, training, and after-sales supportThe company expects the first phase of redevelopment to commence later this year, subject to regulatory approvals and planning. FMV will work closely with local authorities, medical stakeholders, and international partners to ensure the facility complements Malacca’s role as a key medical tourism destination.

Next Story
Infrastructure Transport

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Next Story
Infrastructure Urban

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Next Story
Infrastructure Urban

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App